Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 338

1.

Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.

Aoba T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M.

Ann Surg. 2013 Apr;257(4):718-25. doi: 10.1097/SLA.0b013e3182822277.

PMID:
23407295
2.

Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.

Ito K, Ito H, Allen PJ, Gonen M, Klimstra D, D'Angelica MI, Fong Y, DeMatteo RP, Brennan MF, Blumgart LH, Jarnagin WR.

Ann Surg. 2010 Apr;251(4):675-81. doi: 10.1097/SLA.0b013e3181d3d2b2.

PMID:
20224368
3.

Lymph node metastasis in intrahepatic cholangiocarcinoma.

Yamamoto M, Takasaki K, Yoshikawa T.

Jpn J Clin Oncol. 1999 Mar;29(3):147-50.

PMID:
10225697
4.

Prognostic impact of lymph node metastasis in distal cholangiocarcinoma.

Kiriyama M, Ebata T, Aoba T, Kaneoka Y, Arai T, Shimizu Y, Nagino M; Nagoya Surgical Oncology Group.

Br J Surg. 2015 Mar;102(4):399-406. doi: 10.1002/bjs.9752. Epub 2015 Jan 22.

PMID:
25611179
5.

The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.

Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, Chung JB.

Ann Surg Oncol. 2009 Nov;16(11):3048-56. doi: 10.1245/s10434-009-0631-1. Epub 2009 Jul 22.

PMID:
19626372
6.

Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma.

Mao K, Liu J, Sun J, Zhang J, Chen J, Pawlik TM, Jacobs LK, Xiao Z, Wang J.

J Gastroenterol Hepatol. 2016 Feb;31(2):417-26. doi: 10.1111/jgh.13072.

7.

The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.

de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, Mega R, Schulick RD, Choti MA, Geller DA, Barroso E, Mentha G, Capussotti L, Pawlik TM.

Cancer. 2012 Oct 1;118(19):4737-47. doi: 10.1002/cncr.27492. Epub 2012 Mar 13.

8.

Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?

Hakeem AR, Marangoni G, Chapman SJ, Young RS, Nair A, Hidalgo EL, Toogood GJ, Wyatt JI, Lodge PA, Prasad KR.

Eur J Gastroenterol Hepatol. 2014 Sep;26(9):1047-54. doi: 10.1097/MEG.0000000000000162.

PMID:
25051217
9.

Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections.

Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y.

Ann Surg. 2013 Jul;258(1):129-40. doi: 10.1097/SLA.0b013e3182708b57.

PMID:
23059502
10.

Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.

Li SQ, Liang LJ, Hua YP, Peng BG, He Q, Lu MD, Chen D.

Chin Med J (Engl). 2009 Oct 5;122(19):2286-91.

PMID:
20079127
11.

Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma.

Guglielmi A, Ruzzenente A, Campagnaro T, Valdegamberi A, Bagante F, Bertuzzo F, Conci S, Iacono C.

J Gastrointest Surg. 2013 Nov;17(11):1917-28. doi: 10.1007/s11605-013-2331-1. Epub 2013 Sep 19.

PMID:
24048613
12.

Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.

Natsume S, Ebata T, Yokoyama Y, Igami T, Sugawara G, Shimoyama Y, Nagino M.

Ann Surg. 2012 Apr;255(4):754-62. doi: 10.1097/SLA.0b013e31824a8d82.

PMID:
22367444
13.

Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.

Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.

Hepatogastroenterology. 2002 Mar-Apr;49(44):311-6.

PMID:
11995440
14.

Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.

Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T.

Ann Surg Oncol. 2008 Feb;15(2):590-9. Epub 2007 Dec 5.

PMID:
18057991
15.

[Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].

Yu WL, Zhang YJ, Dong H, Yu H, Xian ZH, Wu MC, Cong WM.

Zhonghua Wai Ke Za Zhi. 2009 Aug 1;47(15):1162-6. Chinese.

PMID:
20021908
16.
17.

Lymph nodal involvement as prognostic factor in gallbladder cancer: location, count or ratio?

Negi SS, Singh A, Chaudhary A.

J Gastrointest Surg. 2011 Jun;15(6):1017-25. doi: 10.1007/s11605-011-1528-4. Epub 2011 Apr 13.

PMID:
21487831
18.

Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.

Urahashi T, Yamamoto M, Ohtsubo T, Katsuragawa H, Katagiri S, Takasaki K.

Hepatogastroenterology. 2007 Mar;54(74):346-9.

PMID:
17523271
19.

Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.

Uenishi T, Kubo S, Yamazaki O, Yamada T, Sasaki Y, Nagano H, Monden M.

J Hepatobiliary Pancreat Surg. 2008;15(4):417-22. doi: 10.1007/s00534-007-1315-5. Epub 2008 Aug 1.

PMID:
18670844
20.

Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.

Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T.

J Surg Oncol. 2007 Mar 1;95(3):207-12.

PMID:
17278119

Supplemental Content

Support Center